# Phase II Clinical Study of TR-012001 in Japanese Patients With Parkinson's Disease

> **NCT06212089** · PHASE2 · COMPLETED · sponsor: **SNLD, Ltd.** · enrollment: 12 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** TR-012001
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06212089
- **Lead sponsor:** SNLD, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-28
- **Primary completion:** 2024-04-26
- **Final completion:** 2024-05-30
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2024-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06212089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06212089, "Phase II Clinical Study of TR-012001 in Japanese Patients With Parkinson's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06212089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*